KALA BIO, Inc. Share Price
NASDAQ: KALA | Micro CapKALA BIO, Inc. Stock Performance
KALA BIO, Inc. Share Price Today
As of 9 October 2026, KALA BIO, Inc.'s share price is $0.30. The stock opened at $0.33, compared to its previous close of $0.35. During today's trading session, KALA BIO, Inc.'s share price traded between $0.29 and $0.33, with an average price of $0.31. Over the past 52 weeks, the stock has recorded a high of $3.90 and a low of $0.07. In terms of performance, KALA BIO, Inc.'s share price has risen by 183.05% over the last six months and is down 60.37% on a year-on-year basis.
KALA BIO, Inc. Share Price Chart
KALA BIO, Inc. Quarterly Profit & Loss
All figures in USD
KALA BIO, Inc. Annual Profit & Loss
All figures in USD
About KALA BIO, Inc.
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
KALA BIO, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.43 | $0.29 | -31.78% |
Sep 2026 | $0.52 | $0.43 | -47.29% |
Aug 2026 | $0.76 | $0.81 | +3.18% |
Jul 2026 | $1.80 | $0.79 | -54.64% |
Jun 2026 | $2.29 | $1.74 | -22.20% |
May 2026 | $0.11 | $2.23 | +2,023.81% |
Apr 2026 | $0.19 | $0.10 | -39.66% |
Mar 2026 | $0.38 | $0.17 | -54.57% |
Feb 2026 | $0.52 | $0.38 | -26.49% |
Jan 2026 | $0.58 | $0.52 | -5.96% |
Dec 2025 | $1.29 | $0.55 | -41.93% |
Nov 2025 | $0.75 | $0.95 | +27.20% |